Trial Profile
Retrospective analysis of the substitution of insulin degludec for conventional insulin in patients with type 2 diabetes mellitus.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Jul 2015
Price :
$35
*
At a glance
- Drugs Insulin degludec (Primary) ; Insulin detemir; Insulin glargine; Insulin suspension isophane
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 30 Jul 2015 New trial record
- 09 Jun 2015 Results presented at the 75th Annual Scientific Sessions of the American Diabetes Association.